SC 13G Filing

Company

Karyopharm Therapeutics Inc.

Filed

January 20, 2023

Accession Number

0001306550-23-001542

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →